Knowles Corporation (KN) 2023 Q4 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Knowles fourth-quarter and full-year 2023 earnings call. Today's conference is being recorded. (Operator Instructions)

    下午好。我叫 Audra,今天將擔任本次電話會議的接線員。此刻,我謹代表公司歡迎各位參加 Knowles 2023 年第四季及全年財報電話會議。今天的會議將被錄音。(接線員指示)

  • At this time, I would like to turn the conference over to Sarah Cook. Please go ahead.

    此刻,我想將會議交給 Sarah Cook。請開始。

  • Sarah Cook - VP of Investor Relations

    Sarah Cook - VP of Investor Relations

  • Thank you, Audra, and welcome to our Q4 and full-year 2023 earnings call. I'm Sarah Cook, Vice President of Investor Relations. And presenting with me today are Jeffrey Niew, our President and CEO; and John Anderson, our Senior Vice President and CFO.

    謝謝你,Audra,也歡迎各位參加我們 2023 年第四季及全年財報電話會議。我是 Sarah Cook,投資人關係副總裁。今天與我一同出席的還有:我們的總裁兼執行長 Jeffrey Niew,以及我們的資深副總裁兼財務長 John Anderson。

  • Our call today will include remarks about future expectations, plans, and prospects for Knowles, which constitute forward-looking statements for purposes of Safe Harbor provisions under applicable federal securities laws. Forward-looking statements in this call will include comments about demand for company products; anticipated trends in company's sales, expenses, and profits; and involve a number of risks and uncertainties that could cause actual results to differ materially from current expectations.

    今天的電話會議將包含關於 Knowles 未來預期、計畫與前景的說明,依適用之聯邦證券法之「安全港」條款,這些內容構成前瞻性陳述。本次電話會議中的前瞻性陳述將包括對公司產品需求、公司銷售、費用與獲利之預期趨勢等評論,並涉及多項風險與不確定性,可能導致實際結果與目前預期出現重大差異。

  • The company urges investors to review the risks and uncertainties in the company's SEC filings, including, but not limited to, the annual report on Form 10-K for the fiscal year ended December 31, 2022, periodic reports filed from time to time with the SEC, and risks and uncertainties identified in today's earnings release. All forward-looking statements are made as of the date of this call, and Knowles disclaims any duty to update such statements except as required by law.

    公司敦促投資人查閱公司向 SEC 提交文件中所揭露的風險與不確定性,包括但不限於截至 2022 年 12 月 31 日止會計年度的 Form 10-K 年報、不定期向 SEC 提交的定期報告,以及今日財報新聞稿中所辨識的風險與不確定性。所有前瞻性陳述均以本次電話會議日期為準,除法律要求外,Knowles 不承擔更新此類陳述之任何義務。

  • In addition, pursuant to Reg G, any non-GAAP financial measures referenced during today's conference call can be found in our press release posted on our website at knowles.com and in our current report on Form 8-K filed today with the SEC, including a reconciliation to the most directly comparable GAAP measure. All financial references on this call will be on a non-GAAP continuing operations basis unless otherwise indicated. We've made selected financial information available in webcast slides, which can be found in the Investor Relations section of our webcast.

    此外,依 Reg G 規定,今日電話會議中提及的任何非 GAAP 財務衡量指標,均可在我們發布於 knowles.com 的新聞稿,以及今日向 SEC 提交的 Form 8-K 當期報告中查閱,其中包含與最直接可比之 GAAP 指標的調節表。除非另有說明,本次電話會議中所有財務數據皆以非 GAAP 的持續營運基礎呈現。我們已在網路直播投影片中提供部分精選財務資訊,可於我們網路直播的投資人關係專區查閱。

  • With that, please let me turn the call over to Jeff, who will provide details on our results. Jeff?

    接下來,讓我把電話交給 Jeff,由他說明我們的業績細節。Jeff?

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Thanks, Sarah, and thanks to all of you for joining us today. Before I get into the Q4 results and my remarks on the status of our markets and what we are seeing for Q1, I would like to start off with some highlights from the previous year. We again made significant progress in transforming our business to higher-value products, which we believe will drive increased shareholder value in the years to come. In our medtech and specialty audio business, after a large inventory correction in the first half, we delivered 17% sequential revenue growth in the second half of 2023 with strong operating margins. Our operational performance, coupled with the success of our new products, gives us great momentum as we enter 2024.

    謝謝你,Sarah,也感謝各位今天加入我們。在我進入第四季業績,以及我對市場現況與我們對第一季所見情況的評論之前,我想先分享一些去年的重點。我們再次在將業務轉型至更高價值產品方面取得顯著進展,我們相信這將在未來幾年帶動股東價值提升。在我們的醫療科技與專業音訊業務方面,儘管上半年經歷大幅庫存修正,我們在 2023 年下半年仍實現 17% 的連續營收成長,且營業利潤率表現強勁。我們的營運表現,加上新產品的成功,讓我們在邁入 2024 年之際具備強勁動能。

  • In our precision device segment, we successfully completed the acquisition of Cornell Dubilier, which significantly expands our total available market for capacitors in key markets and drives opportunities for future growth. Since closing in Q4, we now believe the synergies will be higher than our initial expectations.

    在精密元件(Precision Device)事業部方面,我們成功完成對 Cornell Dubilier 的收購,這大幅擴展了我們在關鍵市場中電容器的整體可服務市場(TAM),並帶來未來成長機會。自第四季完成交割以來,我們目前認為可實現的綜效將高於最初預期。

  • Lastly, the company closed out 2023 with another strong year of free cash flow of $106 million or 15% of revenues. This has allowed us to continue to fund organic growth and look at additional acquisition opportunities in our target markets, all while continuing to buy back shares and keeping our debt at very manageable levels. We are very excited about the direction we are heading and believe we will continue to drive shareholder value in 2024 and beyond.

    最後,公司在 2023 年以另一個強勁的自由現金流年度作結,自由現金流達 1.06 億美元,約占營收的 15%。這使我們得以持續投入有機成長,並在目標市場中評估更多併購機會,同時持續回購股票,並將負債維持在非常可控的水準。我們對前進方向感到非常振奮,並相信在 2024 年及未來將持續創造股東價值。

  • Now onto our Q4 results. We delivered revenue of $215 million and EPS of $0.28 within our guidance range, with cash from operations of $60 million, which was above the high end of our guided range. Turning to segment results, medtech and specialty audio revenue was up 9% versus the same period a year ago. The hearing health market continues to perform well, and we are expecting strong year-over-year growth in the first half of 2024. The dynamics of aging populations in western economies, expansion of the middle class globally, and increasing penetration of people with mild to moderate hearing loss all point to positive market dynamics in the mid to long term.

    接著談第四季業績。我們實現營收 2.15 億美元、每股盈餘(EPS)0.28 美元,皆落在我們的財測區間內;營運活動現金流為 6,000 萬美元,高於我們指引區間的上緣。就各事業部表現而言,醫療科技與專業音訊(MSA)營收較去年同期成長 9%。聽力健康市場持續表現良好,我們預期 2024 年上半年將有強勁的年增成長。西方經濟體人口老化、全球中產階級擴張,以及輕度至中度聽損族群滲透率提升等因素,皆顯示中長期市場動能正向。

  • Precision device revenue was up 10% year over year, including the acquisition of Cornell. While inventory in the channel remains high, specifically in industrial and distribution and with a number of OEM customers, underlying demand appears to be stable and design activity across our core markets remains high. With this backdrop, we expect increased earnings for PD in 2024 as we focus on cost controls and capacity utilization and optimization. Earnings growth will be driven by organic gross margin improvement and the Cornell acquisition and its associated synergies. Channel inventory normalization expected in the second half of 2024 will complement our expected earnings growth.

    精密元件(PD)營收年增 10%,其中包含 Cornell 收購的貢獻。儘管通路庫存仍偏高,特別是在工業與經銷通路以及部分 OEM 客戶端,但基礎需求看起來仍然穩定,而我們核心市場的設計導入活動依舊活躍。在此背景下,隨著我們聚焦成本控管與產能利用率及最佳化,我們預期 2024 年 PD 的獲利將提升。獲利成長將由有機毛利率改善,以及 Cornell 收購及其相關綜效所帶動。預期於 2024 年下半年出現的通路庫存正常化,也將有助於我們預期的獲利成長。

  • Turning to the consumer MEMS microphone business, we continue to move forward with the exploration of strategic alternatives. In the quarter, revenue was up 8% from the same period a year ago. We have now seen three quarters of sequential growth driven by growing demand in non-mobile products, expanded mobile share, and the ongoing recovery in the PC market. We expect to see strong year-over-year revenue and earnings growth in the first quarter of 2024.

    再來談消費性 MEMS 麥克風(CMM)業務,我們持續推進對策略替代方案的評估。本季營收較去年同期成長 8%。我們目前已連續三季呈現逐季成長,主要受非手機產品需求增加、手機市占擴大,以及 PC 市場持續復甦所帶動。我們預期 2024 年第一季將出現強勁的年增營收與獲利成長。

  • To summarize, MSA continues to perform well and the momentum shown in Q4 gives us confidence in 2024 revenue and earnings growth. In PD, we are expecting channel inventory to correct and demand recovery to begin in the back half of 2024. Synergies identified in association with the Cornell acquisition are projected to be higher than initially expected, beginning to materialize in the second half of 2024. For CMM, we expect to achieve modest full-year revenue growth in 2024.

    總結來說,MSA 持續表現良好,第四季展現的動能讓我們對 2024 年營收與獲利成長更具信心。在 PD 方面,我們預期通路庫存將持續修正,需求復甦將於 2024 年下半年開始。與 Cornell 收購相關所辨識的綜效,預估將高於最初預期,並將自 2024 年下半年開始逐步顯現。至於 CMM,我們預期 2024 年全年可達成溫和的營收成長。

  • While 2023 was a challenging year, we performed well in the second half. Heading into 2024, I'm optimistic we have growth across all three of our business units in revenue and total company earnings, along with continued robust cash flow. We continue to transform our company to higher-value products and markets, and I'm confident the strategic actions we've taken will drive long-term shareholder value.

    雖然 2023 年充滿挑戰,但我們在下半年表現良好。展望 2024 年,我樂觀認為我們三個事業單位在營收與公司整體獲利方面都將實現成長,同時維持強勁的現金流。我們持續將公司轉型至更高價值的產品與市場,我有信心我們所採取的策略行動將帶動長期股東價值。

  • Before I turn it over to John, remember, we will be providing revenue, EPS, and cash from operations guidance. As I said in Q3, we believe these metrics are the best measures for our business and are aligned to the company's focus.

    在我把電話交給 John 之前提醒各位,我們將提供營收、EPS 與營運活動現金流的財測指引。如同我在第三季所說,我們認為這些指標最能衡量我們的業務表現,並與公司的聚焦方向一致。

  • Now let me turn the call over to John to detail our quarterly and annual results and guidance. John?

    現在讓我把電話交給 John,請他說明我們季度與年度業績以及財測指引。John?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Thanks, Jeff. We reported fourth-quarter revenues of $215 million in line with guidance and up 9% from the year ago period, driven by the acquisition of Cornell, which we completed on November 1. EPS was $0.28 in the quarter within our guidance range and $0.05 below prior year levels. In the medtech and specialty audio segment, revenue was $67 million, up 9% versus the fourth quarter of 2022, an increased demand in the hearing health market. Gross margins were 54.2%, up 260 basis points versus the prior year, driven by factory productivity improvements, favorable product mix, and foreign currency impacts. The precision device segment delivered revenues of $70 million, up 10% from the prior year, driven by the acquisition of Cornell, partially offset by lower shipments into the distribution and industrial end markets as we continue to see excess channel inventory.

    謝謝,Jeff。我們公布第四季營收為2.15億美元,符合指引,並較去年同期成長9%,主要受惠於我們於11月1日完成的Cornell收購案。本季每股盈餘(EPS)為0.28美元,落在我們的指引區間內,但較去年同期低0.05美元。在醫療科技與專業音訊(medtech and specialty audio)事業部門,營收為6,700萬美元,較2022年第四季成長9%,反映聽力健康市場需求增加。毛利率為54.2%,較去年同期提升260個基點,主要受工廠生產力改善、有利的產品組合以及外匯影響所帶動。精密裝置(precision device)事業部門營收為7,000萬美元,較去年同期成長10%,主要受Cornell收購帶動,但因通路與工業終端市場出貨下滑而部分抵銷,因我們仍持續看到通路庫存過剩。

  • Gross margins were 35.4%, down 13 percentage points versus the prior year due to lower factory capacity utilization and the acquisition of Cornell. Consumer MEMS microphone revenues of $78 million were up 8% versus the prior year, driven by higher shipments into the mobile and compute markets. Although full-year revenues were down 12% in 2023, driven by an extremely weak first quarter, we delivered sequential revenue growth over the remainder of the year through a combination of market growth and share gains.

    毛利率為35.4%,較去年同期下降13個百分點,原因是工廠產能利用率較低以及Cornell收購的影響。消費性MEMS麥克風營收為7,800萬美元,較去年同期成長8%,主要受惠於對行動與運算市場的出貨增加。儘管2023年全年營收下滑12%,主要是因第一季極度疲弱所致,但我們在其後各季透過市場成長與市占提升的組合,實現了逐季營收成長。

  • Gross margins were 24.7%, 70 basis points above the same period a year ago on higher factory capacity utilization. On a total company basis, R&D expense in the quarter was $16 million, up slightly compared to the prior year. SG&A expenses were $31 million, $4 million higher than prior year levels driven by the acquisition of Cornell and an increase in professional and legal fees associated with the exploration of strategic alternatives for CMM.

    毛利率為24.7%,較去年同期高70個基點,主要因工廠產能利用率提高。以公司整體而言,本季研發(R&D)費用為1,600萬美元,較去年同期小幅增加。銷售、一般及行政(SG&A)費用為3,100萬美元,較去年同期增加400萬美元,主要受Cornell收購影響,以及因探索CMM策略替代方案而增加的專業與法律費用。

  • Now I'll turn to our balance sheet and cash flow. We generated $60 million in cash from operating activities in the quarter, and capital spending was $5 million. We also repurchased approximately 1.2 million shares at a total cost of $20 million and ended the year with cash and cash equivalents of $87 million. On a full-year basis, free cash flow was $106 million or 15% of revenues, and we repurchased approximately 2.9 million shares at a cost of $48 million. We exited 2023 with $271 million of debt, which includes $160 million of borrowings under our revolving credit facility and a seller note which was issued in connection with the Cornell acquisition. Lastly, our net leverage ratio was 1.3 times 2023 EBITDA.

    接下來我將說明資產負債表與現金流。本季我們自營運活動產生6,000萬美元現金,資本支出為500萬美元。我們也以總成本2,000萬美元回購約120萬股,並於年底持有現金及約當現金8,700萬美元。以全年而言,自由現金流為1.06億美元,約占營收的15%,我們並以4,800萬美元回購約290萬股。我們於2023年底的負債為2.71億美元,其中包含循環信用額度項下借款1.6億美元,以及與Cornell收購相關所發行的賣方票據(seller note)。最後,我們的淨槓桿比率為2023年EBITDA的1.3倍。

  • Now moving to our guidance. For the first quarter of 2024, revenues are expected to be between $190 million and $200 million, up 35% versus the year ago period, driven by both organic growth and the acquisition of Cornell. R&D expenses are expected to be between $17 million and $18 million. And selling and administrative expenses are expected to be within the range of $30 million to $32 million, up from prior year due to the Cornell acquisition. We're projecting adjusted EBIT margin for the quarter to be within a range of 12% to 14%. We're forecasting interest expense in Q1 to be between $5 million and $7 million, which includes approximately $2 million of non-cash imputed interest.

    接著談我們的財測指引。2024年第一季,預期營收介於1.90億至2.00億美元,較去年同期成長35%,成長動能來自有機成長以及Cornell收購。研發費用預期介於1,700萬至1,800萬美元。銷售與管理費用預期介於3,000萬至3,200萬美元,因Cornell收購而較去年提高。我們預估本季調整後EBIT利潤率介於12%至14%。我們預估第一季利息費用介於500萬至700萬美元,其中包含約200萬美元的非現金推算利息(non-cash imputed interest)。

  • For full-year 2024, we expect interest expense of $22 million, and we expect an effective tax rate of 14% to 16% for both the quarter and full-year 2024. We're projecting EPS to be within a range of $0.16 to $0.20 per share, up $0.13 from the year ago period. This assumes weighted average shares outstanding during the quarter of $94 million on a fully diluted basis. Lastly, we're projecting cash from operations to be within a range of $0 to $10 million, and capital spending is expected to be $5 million.

    2024年全年,我們預期利息費用為2,200萬美元;且無論是本季或2024年全年,我們預期有效稅率為14%至16%。我們預估每股盈餘(EPS)介於每股0.16至0.20美元,較去年同期增加0.13美元。此假設本季完全稀釋後加權平均流通股數為9,400萬股。最後,我們預估營運活動現金流介於0至1,000萬美元,資本支出預期為500萬美元。

  • I'll now turn the call back over to the operator for the questions and answers portion of our call. Operator?

    接下來我把電話交回給接線員,進入問答環節。接線員?

  • Operator

    Operator

  • (Operator Instructions) Christopher Rolland, Susquehanna.

    (接線員指示) Susquehanna的Christopher Rolland。

  • Christopher Rolland - Analyst

    Christopher Rolland - Analyst

  • Hey, guys, thanks so much for the question. So I guess, you talked about some excess channel inventory in some of your end markets. I was wondering if you could perhaps flesh that out for us and maybe discuss how this might affect kind of future revenues as we -- or areas as we look through 2024. Thank you.

    各位好,謝謝讓我提問。我想你們提到在部分終端市場存在一些通路庫存過剩。想請你們能否再多說明一下,並談談當我們展望2024年時,這可能會如何影響未來營收或相關領域。謝謝。

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Yeah, thanks, Chris, for the question. So what I would say is the primary area that we see a lot of inventory is what we call it in the industrial/distribution channels. And we've listened to some of the big distributors calls, they're seeing a fair amount of channel inventory and it is impacting our business, no doubt, specifically in the PD segment, both in the Cornell portion as well as the traditional PD portion.

    好的,Chris,謝謝你的問題。我會說,我們看到庫存最多的主要區域是在我們所稱的工業/通路(industrial/distribution)渠道。我們也聽了一些大型通路商的法說,他們看到相當程度的通路庫存,這無疑正在影響我們的業務,特別是在PD事業部門,包含Cornell的部分以及傳統PD的部分。

  • Now we're hearing a lot that there may be -- again, people are projecting the recovery in the back half of the year. But I think what we're focused on in the first half is, number one, we do have strong organic growth in the first quarter, and it's being driven primarily by our MSA business as well as our CMM business; and of course, the additional revenue we get from Cornell through the acquisition, that's the inorganic portion. And into that end, we -- again, I think we're really focused in on cost here in the short term, making sure we're optimizing our factory utilization, getting value creation in our factories, as well as cost control and OpEx.

    目前我們聽到很多說法認為——再次強調——大家預期復甦會在下半年出現。但我認為我們在上半年聚焦的是:第一,我們第一季確實有強勁的有機成長,主要由MSA業務以及CMM業務帶動;當然,透過收購Cornell帶來的額外營收則是非有機的部分。基於此,我們——再次強調——短期內非常專注於成本,確保最佳化工廠產能利用率、在工廠端創造價值,同時也做好成本控管與營運費用(OpEx)管理。

  • And so those are things that we're going to be focused on until we see the recovery. But in the meantime, in a number of our businesses, we are seeing very little channel inventory problem at this point, but primarily industrial and distribution.

    因此,在看到復甦之前,這些將是我們會持續聚焦的事項。但同時,在我們多項業務中,目前幾乎看不到通路庫存問題,主要集中在工業與通路領域。

  • Christopher Rolland - Analyst

    Christopher Rolland - Analyst

  • Excellent. And sorry for this all-encompassing question, but we'd love to know, for March, you guys gave top line and bottom line, but would kind of love to know the moving parts on the kind of sequential changes by segment. And then also, to get to your EPS guidance, any clues on the balance between gross margin and OpEx, how those trend? And then lastly, John, I had a little bit of a question mark, getting to your cash from operations. I assume there's some working capital adjustments, but would love to know what those were. Thanks, sorry.

    很好。另外抱歉這個包山包海的問題:你們對3月(季度)給了營收與獲利端的指引,但我們也很想了解各事業部門逐季變動的構成因素。此外,為了達到你們的EPS指引,毛利率與營運費用(OpEx)之間的平衡如何?它們的趨勢是什麼?最後,John,我對你們的營運活動現金流有點疑問。我猜應該有一些營運資金調整,但也想了解具體是哪些。謝謝,不好意思。

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Okay. So I'll handle the revenue portion by segment. I think as I always kind of said, in the microphone business, we do expect strong year-over-year growth in the CMM business year over year. It is down sequentially, but probably a little less significantly than we normally see. We're still seeing quite good demand in Q1. So it's seasonally down as we would normally expect in a normal year. And then our MSA business, it is seasonally down.

    好的。我先按事業部門來說明營收部分。我想如同我一貫所說,在麥克風業務方面,我們確實預期CMM業務的年對年成長會很強勁。它在季對季上會下滑,但可能不會像我們通常看到的那麼明顯。我們在第一季仍看到相當不錯的需求。因此它會如同正常年度的情況一樣,呈現季節性下滑。至於我們的MSA業務,也會呈現季節性下滑。

  • Q4 typically is our strongest quarter in our hearing health market, where we have a big hearing aid show, where products are launched in early Q4. A lot of building goes on in Q4, so seasonally, Q1 is usually lower. But again, our hearing health business is up pretty significantly year over year.

    第四季通常是我們聽力健康市場最強勁的季度,因為我們有一個大型助聽器展會,產品會在第四季初推出。第四季會進行大量的建置與準備,因此從季節性來看,第一季通常較低。但再說一次,我們的聽力健康業務年對年成長相當顯著。

  • And then if you go to the precision device segment, you would sit there and you look in total, it's up pretty significantly sequentially -- or sorry, it's up marginally sequentially, a lot being driven by the Cornell acquisition.

    接著如果你看精密裝置事業部,你會看到整體而言,它的表現按季來看成長相當明顯——或抱歉,按季僅小幅成長,其中很大一部分是由 Cornell 併購案所帶動。

  • I'll turn it over to John to talk more about on the EPS and the cash flow numbers.

    我把時間交給 John,請他再多談談每股盈餘(EPS)以及現金流的數字。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Yes, sure. So Chris, in my prepared remarks, I provided for Q1 revenue guidance, I provided OpEx, both R&D and SG&A, as well as EBIT margins. The only thing I really didn't specifically talk about is gross margins, but you can kind of think of the gross margins being very similar to Q4 levels in Q1. And then we expect sequential increases over the remainder of 2024. I think that was the first piece. I also provided the interest expense and taxes. So I think you have all of the mechanics to get to that EPS guidance we have. I think your other question was on free cash flow?

    好的,當然。Chris,在我事先準備的發言中,我提供了第一季營收指引,也提供了營業費用(OpEx),包含研發(R&D)與銷售、一般及行政費用(SG&A),以及 EBIT 利潤率。我唯一沒有特別談到的是毛利率,但你可以把第一季的毛利率大致視為與第四季水準非常接近。然後我們預期在 2024 年剩餘期間毛利率會逐季提升。我想那是第一部分。我也提供了利息費用與稅負。所以我認為你已經具備推導出我們 EPS 指引所需的所有機制。我想你另一個問題是關於自由現金流?

  • Christopher Rolland - Analyst

    Christopher Rolland - Analyst

  • Yeah, it was cash from operations specifically. And I apologize, I joined the call a little late.

    對,是特別指營運活動現金流。也抱歉,我加入電話會議稍微晚了一點。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Yeah. So cash from operations, very strong in both Q4 and for the full year. And I would say, a lot of this is sustainable. We did have a benefit in 2023 for a reduction of inventory, about $14 million. When you look at the balance sheet, it's a little camouflaged because you have the inventory related to the Cornell acquisition. But if you strip that out, the inventory, I'll call the legacy business, down about $15 million, which created some tailwind.

    是的。所以營運活動現金流在第四季以及全年都非常強勁。我會說其中很大一部分是可持續的。我們在 2023 年確實因為庫存降低而受益,約 1,400 萬美元。當你看資產負債表時,這點有些被掩蓋,因為你還有 Cornell 併購案相關的庫存。但如果把那部分剔除,我稱之為既有業務的庫存約減少 1,500 萬美元,帶來了一些順風。

  • I'd also say from a free cash flow standpoint, CapEx were lower than normal. They were extremely low for full-year '23. I think we pushed out some projects and really focused on investments with highest ROI. So I would say that could tick up a little bit going into 2024, more to like a 3% to 5% of revenue range.

    另外從自由現金流的角度來看,資本支出(CapEx)低於正常水準。2023 全年的資本支出非常低。我想我們把一些專案往後延,並且更聚焦在投資報酬率(ROI)最高的投資上。所以我會說,進入 2024 年後資本支出可能會小幅回升,大概到營收的 3% 到 5% 區間。

  • Christopher Rolland - Analyst

    Christopher Rolland - Analyst

  • Okay. I was specifically talking about the guide for cash from operations at [1 to 10]. I was wondering if there was some working capital adjustments in there to get there?

    好的。我特別是在談營運活動現金流的指引在[1 到 10]。我想知道為了達到那個數字,裡面是否包含一些營運資金的調整?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • For Q1, Q1 is seasonally our lowest free cash flow and cash from ops quarter. You can go back to Q1 of '22 or '23 and you'll see that. We have bonus payouts in Q1. That's a big outflow. But from the other components of net working capital, there's not a huge swing. There will be some increases in inventory as we're building, taking in raw materials and building for ramp-ups later in the year. So there may be a little headwind in the quarter. But again, Q1 is historically (multiple speakers) cash flow standpoint.

    就第一季而言,第一季在季節性上是我們自由現金流與營運現金流最低的季度。你可以回頭看 2022 或 2023 年的第一季,就會看到這點。我們在第一季會發放獎金。那是一筆很大的現金流出。但就淨營運資金的其他組成項目而言,變動不會很大。隨著我們在建置、採購原物料並為年內稍後的產能爬坡做準備,庫存會有一些增加。所以本季可能會有一點逆風。但再說一次,從歷史來看第一季在(多位發言者)現金流的角度一直都是如此。

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Even though Q1 is historically low, we're still expecting for the full year to have a very robust year again in terms of free cash flows.

    即使第一季歷來偏低,我們仍預期全年在自由現金流方面會再次非常強勁。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Similar, maybe a touch lower than 2023. But again, pretty strong cash flow for the full year. So I caution just looking at one quarter.

    可能與 2023 年相近,或略低一些。但再說一次,全年現金流仍相當強勁。所以我提醒不要只看單一季度。

  • Christopher Rolland - Analyst

    Christopher Rolland - Analyst

  • Thank you, guys.

    謝謝各位。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Yes, thanks, Chris.

    好的,謝謝你,Chris。

  • Operator

    Operator

  • Bob Labick, CJS Securities.

    Bob Labick,CJS Securities。

  • Lee Jagoda - Analyst

    Lee Jagoda - Analyst

  • Hi. It's actually Lee Jagoda for Bob today. Just starting with the CMM business and the strategic alternatives process, can you give us any kind of timeframe for a decision one way or the other, whether it be first half, second half? Is it a 2025 event? And then I've got some follow-ups.

    嗨。今天其實是我 Lee Jagoda 代替 Bob。先從 CMM 業務以及策略替代方案流程開始,你們能否提供任何決策時程的概念——不論最後是做或不做——例如上半年、下半年?會是 2025 年的事件嗎?然後我還有一些追問。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Obviously, we're trying to move this process along as quickly as we can, but there's no definitive timeline at all to complete this. So that's what I'd say for now. And the process is progressing.

    很明顯地,我們正盡可能加快推進這個流程,但完成此事並沒有任何明確的時間表。所以目前我只能這麼說。而且流程正在推進中。

  • Lee Jagoda - Analyst

    Lee Jagoda - Analyst

  • And then I guess in your prepared remarks, it sounds like the business is faring relatively well at the moment. What do you see as sort of the key drivers or variables to 2024 results and how that might impact the process that's going on?

    那我想在你們事先準備的發言中,聽起來目前業務表現相對不錯。你們認為 2024 年業績的關鍵驅動因素或變數是什麼?以及這可能如何影響正在進行的流程?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Well, I mean, what I would say you're right, 2023, especially the back half, after a very difficult front-half, specifically Q1 of '23, the back half shaped up pretty well. And Q1 is looking very, very well as well. And so the dynamics here really are we've got a number of new product introductions on our side that are -- and some of our customers [do] products, coupled with some share gains that we've seen and some market recovery.

    嗯,我的意思是,我會說你說得沒錯,2023 年,尤其是在上半年非常艱難之後——特別是 2023 年第一季——下半年表現相當不錯。而第一季看起來也非常、非常好。因此這裡的動態主要是:我們這邊有多項新產品導入——以及我們的一些客戶也[會]推出產品——再加上我們看到的一些市占提升與市場復甦。

  • So I think overall -- I mean, we're expecting modest growth on revenue side year over year. I wouldn't expect some kind of crazy growth number this year. But we expect modest growth, and I think it's in line with our expectations that we had three months ago.

    所以我認為整體而言——我們預期營收端年對年會有溫和成長。我不會預期今年會出現什麼瘋狂的成長數字。但我們預期是溫和成長,而且我認為這與我們三個月前的預期一致。

  • Lee Jagoda - Analyst

    Lee Jagoda - Analyst

  • And then just one last one for me. So had you not had such strong free cash flow in Q4, it sounds like you would have hit your goal of returning 50% of free cash flow to shareholders through repurchase (multiple speakers)

    然後我最後一個問題。所以如果你們第四季沒有那麼強的自由現金流,聽起來你們本來就會達成透過庫藏股回購把自由現金流的 50% 回饋給股東的目標(多位發言者)

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Good catch, good catch. Yeah, we came in at just under 50%, and it's because December free cash flow is really stronger than we anticipated. But I think it's close; it's probably 45% versus a 50% return.

    抓得好,抓得好。是的,我們最後略低於 50%,原因是 12 月的自由現金流比我們預期的還要強。但我認為很接近;大概是回饋 45%,而不是 50%。

  • Lee Jagoda - Analyst

    Lee Jagoda - Analyst

  • And as we look out to 2024, even if we don't have a sale to pay back some of the loan, is that how we should think about cash deployment?

    那展望 2024 年,即使我們沒有出售資產來償還部分貸款,我們也應該用這種方式來理解現金的運用嗎?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Yeah, I think there's not a huge change in our capital allocation. Given where interest rates are and given the fact we do have debt borrowings under our revolver now, we are evaluating, is it more advantageous to pay down debt versus repurchasing shares? I think it will be a combination of some combination of that. But we are evaluating it, given when we set that 50% free cash flow return, interest rates were significantly lower. So we're evaluating.

    是的,我認為我們的資本配置不會有很大的改變。考量目前的利率水準,以及我們現在在循環信貸(revolver)下確實有借款,我們正在評估:相較於回購股票,償還債務是否更有利。我想最終會是兩者的某種組合。但我們正在評估,因為當初我們設定 50% 自由現金流回饋時,利率明顯更低。所以我們正在評估。

  • Lee Jagoda - Analyst

    Lee Jagoda - Analyst

  • That's fair. Thanks very much.

    這很合理。非常感謝。

  • Operator

    Operator

  • Tristan Gerra, Baird.

    Tristan Gerra,Baird。

  • Tristan Gerra - Analyst

    Tristan Gerra - Analyst

  • Hi, good afternoon. Could you break down the revenue contribution from Cornell in Q4 and what's embedded in the Q1 guidance? And then also, if you could expand on the accretion, higher than expected, that you expect from Cornell, what's driving that now that you have some visibility on the business post the close of the purchase.

    嗨,午安。您能否拆解一下 Cornell 在第四季的營收貢獻,以及第一季財測指引中包含了哪些?另外,關於您預期 Cornell 的增厚(高於預期),在收購完成後您對業務有了一些能見度,現在是什麼因素在驅動?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • So you're asking about the revenue specifically from Cornell in Q4?

    所以你是在問第四季 Cornell 的營收,特別是這一塊?

  • Tristan Gerra - Analyst

    Tristan Gerra - Analyst

  • Correct. Q4 and Q1, if possible?

    沒錯。如果可以的話,第四季和第一季?

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • Yeah, it was roughly in line with our expectations for Q4, for two months, at about $20 million in revenue, and EPS neutral. And I would say that the monthly run rate's probably slightly higher than that in Q1, starting to be a little bit higher in Q1 than the $10 million a month in Q1. I would say, if you remember on November 1, when we announced the closing of the deal, we kind of laid out some metrics. So I think on the revenue side, what we said is pretty aligned. I think the EBITDA is pretty close in line, maybe a tad higher.

    是的,第四季兩個月的表現大致符合我們的預期,營收約 2,000 萬美元,對 EPS 為中性。我會說第一季的月度運行率可能會略高一些,第一季開始會比每月 1,000 萬美元略高。我想如果你還記得 11 月 1 日我們宣布交易完成時,我們大致列出了一些指標。所以在營收方面,我們當時說的內容相當一致。我認為 EBITDA 也非常接近,可能略高一點點。

  • But I think the biggest thing we'd talk about here is on the synergies. We had, I think, committed to around $4 million on the cost side at the closing date within 36 months of the close. I think we're on target, maybe slightly ahead on that, the $4 million.

    但我認為我們在這裡要談的最大重點是協同效益。我想我們在交割時承諾在交割後 36 個月內,成本端約 400 萬美元。我認為我們正按計畫進行,可能還略微超前,達成這 400 萬美元。

  • But I think the biggest thing that we've come to bring to the table is that we think there's an opportunity for what I call a product management or pricing to actually raise prices with this business, which I think, if you know, with the lead times, with distribution inventory, it may take a little bit of time for this to kind of really come in and show up in our actual results. So we probably won't see a lot of it start coming till the back half, starting the back half of '24.

    但我認為我們帶來的最大價值是,我們覺得在我所稱的產品管理或定價方面有機會,實際上可以為這項業務提高價格;我想如果你了解交期以及通路庫存的情況,這可能需要一些時間才會真正落地並反映在我們的實際業績中。所以我們可能要到 2024 年下半年才會開始看到較多的貢獻,從 2024 年下半年開始。

  • But I think what I'd say is beyond the $4 million of cost savings, we see now, I would say, a reasonably significant, especially going into '25, improvement in margins from this business, just purely based on pricing,

    但我想我會說,除了 400 萬美元的成本節省之外,我們現在看到,尤其進入 2025 年,這項業務的毛利率將有相當顯著的改善,純粹是基於定價。

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Tristan, just to add a little bit on the accretion. We expect it to be neutral again in Q1. We expect it to be accretive to earnings kind of beginning in the back half of 2024. And I think one thing to point out is in the calculation of accretion, we do include both the cash interest, and then I mentioned this in the script, there's what we call imputed interest. We had a $123 million interest-free loan in connection with that acquisition. So we calculate, using a market rate of about 7.25%, we impute interest. So that's included in that.

    Tristan,我再補充一點關於增厚。我們預期第一季仍將是中性。我們預期從 2024 年下半年開始,對獲利將呈現增厚。我想要指出的一點是,在計算增厚時,我們同時納入現金利息;另外我在講稿中也提到,還有所謂的推算利息(imputed interest)。與該項收購相關,我們有一筆 1.23 億美元的免息貸款。因此我們以約 7.25% 的市場利率來推算利息。所以這也包含在其中。

  • John Anderson - Senior VP & CFO

    John Anderson - Senior VP & CFO

  • I mean, I guess what I'd say, Tristan, overall, we feel pretty good about where we are three months into this, three, four months into this, that this acquisition is really a nice fit for us and we have the opportunity to be a nice grower on the margin side and the EBITDA side, but starting really in the back half of the year.

    我的意思是,Tristan,整體而言,我們對目前的進展感覺相當不錯;在這三個月、三到四個月的時間點,我們認為這項收購確實非常適合我們,而且我們有機會在毛利率與 EBITDA 方面成為不錯的成長動能,但真正開始會是在今年下半年。

  • Tristan Gerra - Analyst

    Tristan Gerra - Analyst

  • Great. And then for my follow-up, within the precision device business, if you could give us some details on how the various segments are moving. I'm guessing just the telecom, industrial, obviously going to be the weakest given the inventory deleveraging that's going on, but any commentary as well on automotive defense? And also, how is the pricing looking like for the capacitor, which is most of that business? And also, if you can remind us whether you have pricing agreements, LTA type of agreements, or is it all spot?

    很好。那我追問一下,在精密元件(precision device)業務方面,您能否提供一些細節,說明各個終端市場的走勢?我猜電信、工業顯然會是最弱的,因為正在進行去庫存,但也請評論一下汽車、國防的情況?另外,電容器(占該業務大部分)的定價目前看起來如何?也請提醒我們,你們是否有定價協議、LTA 類型的長期協議,還是全部都是現貨?

  • Jeffrey Niew - President & CEO

    Jeffrey Niew - President & CEO

  • Yeah. So first, on the pricing, I think we talked about pricing in the Cornell portion of the acquisition. I think we've gone through a lot of the pricing work, obviously in the traditional PD business over the years, but we expect modest price increases in 2024 over 2023. I think the biggest thing that we see in terms of the markets is still this industrial/distribution business still is very, very weak at this moment. And we kind of see this in the Cornell, but we see this in the Cornell business as well. But that was factored into kind of what we said by the November 1 timeline when we announced the closure or the closing on the business.

    好的。先談定價,我想我們已經談過收購案中 Cornell 部分的定價。我認為過去幾年我們在傳統的 PD 業務上已做了大量定價工作,但我們預期 2024 年相較 2023 年會有溫和的漲價。我認為我們在市場端看到的最大重點仍是工業/通路這塊業務目前依然非常、非常疲弱。我們在 Cornell 也看到這種情況,但這已經納入我們在 11 月 1 日宣布交易完成(交割)時所說的內容之中。

  • So it's really about industrial and telecom. There are a few, I would say, large OEMs, which shall remain nameless that [you'll] have some inventory of their own, but I think that should clear up relatively quickly. It's still really about this industrial/distribution business and when we believe that that's going to recover. But in the meantime, where we are really working hard in the factory is to optimize capacity utilization, get value creation in the factories, and control OpEx. That's what we're focused on right now in this interim period, probably through the first half.

    所以重點其實在工業與電信。有幾家我會說是大型 OEM(就不點名了)自身仍有一些庫存,但我認為那應該會相對較快消化。真正的關鍵仍是工業/通路這塊業務,以及我們認為它何時會復甦。但同時,我們在工廠端正非常努力地優化產能利用率、在工廠創造價值,並控制營運費用(OpEx)。這是我們目前在這段過渡期的重點,可能會持續到上半年。

  • Tristan Gerra - Analyst

    Tristan Gerra - Analyst

  • Great. Thank you very much.

    很好。非常感謝。

  • Operator

    Operator

  • And there are no further questions at this time. I would like to turn the conference over to Sarah Cook for closing remarks.

    目前沒有進一步的提問。我想把電話會議交給 Sarah Cook 做結語。

  • Sarah Cook - VP of Investor Relations

    Sarah Cook - VP of Investor Relations

  • Thank you for joining us today. As always, we appreciate your interest in Knowles and look forward to speaking with you on our next earnings call. Thank you, and goodbye.

    感謝各位今天加入我們。一如既往,我們感謝各位對 Knowles 的關注,並期待在下一次財報電話會議中與各位交流。謝謝,再見。

  • Operator

    Operator

  • This concludes today's conference call. Thank you for your participation. You may now disconnect.

    今天的電話會議到此結束。感謝各位的參與。您現在可以掛線。